Risk and Distribution of Metastatic Infections by Primary Infection Focus in Staphylococcus aureus Bacteremia - Scorecard - MDSpire

Risk and Distribution of Metastatic Infections by Primary Infection Focus in Staphylococcus aureus Bacteremia

  • By

  • Seongman Bae

  • Min Soo Kook

  • Euijin Chang

  • Jiwon Jung

  • Min Jae Kim

  • Yong Pil Chong

  • Sung-Han Kim

  • Sang-Ho Choi

  • Sang-Oh Lee

  • Yang Soo Kim

  • June 25, 2025

  • 0 min

Share

Clinical Scorecard: Patterns and Risk of Metastatic Infections Originating from Primary Sites in Staphylococcus aureus Bacteremia

At a Glance

CategoryDetail
ConditionStaphylococcus aureus bacteremia (SAB) with risk of metastatic infections
Key MechanismsHematogenous dissemination of S. aureus from primary infection focus to secondary anatomical sites causing metastatic infections
Target PopulationAdult patients diagnosed with Staphylococcus aureus bacteremia
Care SettingTertiary care hospital setting with infectious disease specialist consultation

Key Highlights

  • 16.7% of SAB patients developed metastatic infections within 90 days, with 85% occurring within the first 7 days post-diagnosis.
  • Incidence of metastatic infections varies by primary infection focus, highest in endocarditis patients (73.4%).
  • Most common metastatic sites are lung (23.7%), bones and joints (16.8%), and central nervous system (12.3%).

Guideline-Based Recommendations

Diagnosis

  • Perform standardized infectious disease consultation at SAB diagnosis.
  • Conduct transthoracic echocardiography to screen for endocarditis.
  • Recommend ophthalmological examination to detect endophthalmitis.
  • Use imaging (CT, MRI) guided by new symptoms or findings suggestive of metastatic infection.

Management

  • Differentiate uncomplicated from complicated SAB; complicated cases require prolonged antibiotic therapy and source control.
  • Implement intensive monitoring and timely interventions for patients with metastatic infections.
  • Follow blood cultures every 1–2 days until negative to confirm clearance.

Monitoring & Follow-up

  • Close monitoring during first 7 days post-diagnosis due to high risk period for metastatic infections.
  • Repeat chart reviews and clinical assessments up to 90 days to detect late metastatic infections or recurrence.

Risks

  • Higher risk of metastatic infection associated with primary endocarditis focus.
  • Community acquisition, prolonged bacteremia, and infective endocarditis are known risk factors.

Patient & Prescribing Data

Adults hospitalized with confirmed Staphylococcus aureus bacteremia

Prolonged antibiotic therapy and source control are critical in complicated SAB cases with metastatic infections; early infectious disease consultation improves standardized care.

Clinical Best Practices

  • Trigger automatic infectious disease consultation upon SAB diagnosis to standardize evaluation.
  • Stratify metastatic infection risk based on primary infection focus to guide targeted diagnostic imaging and specialist referrals.
  • Prioritize early detection and management within the first week post-diagnosis to improve outcomes.
  • Use systematic follow-up blood cultures and echocardiography to monitor infection clearance and detect complications.

References

Original Source(s)

Related Content